These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 9236948)

  • 1. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
    Mohs RC; Knopman D; Petersen RC; Ferris SH; Ernesto C; Grundman M; Sano M; Bieliauskas L; Geldmacher D; Clark C; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S13-21. PubMed ID: 9236948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity and reliability of the Turkish version of Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in patients with mild and moderate Alzheimer's disease and normal subjects.
    Mavioglu H; Gedizlioglu M; Akyel S; Aslaner T; Eser E
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):259-65. PubMed ID: 16477580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.
    Karin A; Hannesdottir K; Jaeger J; Annas P; Segerdahl M; Karlsson P; Sjögren N; von Rosen T; Miller F
    Acta Neurol Scand; 2014 Feb; 129(2):114-22. PubMed ID: 23763450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter evaluation of new treatment efficacy instruments for Alzheimer's disease clinical trials: overview and general results. The Alzheimer's Disease Cooperative Study.
    Ferris SH; Mackell JA; Mohs R; Schneider LS; Galasko D; Whitehouse PJ; Schmitt FA; Sano M; Thomas RG; Ernesto C; Grundman M; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S1-12. PubMed ID: 9236947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Schmitt FA; Ashford W; Ernesto C; Saxton J; Schneider LS; Clark CM; Ferris SH; Mackell JA; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S51-6. PubMed ID: 9236953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAS-cog (Alzheimer's Disease Assessment Scale-cognitive subscale)--validation of the Slovak version.
    Kolibas E; Korinkova V; Novotny V; Vajdickova K; Hunakova D
    Bratisl Lek Listy; 2000; 101(11):598-602. PubMed ID: 11218956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease.
    Ihl R; Ferris S; Robert P; Winblad B; Gauthier S; Tennigkeit F
    Int J Geriatr Psychiatry; 2012 Jan; 27(1):15-21. PubMed ID: 21384431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and test-retest reliability of the international shopping list test in assessing verbal learning and memory in mild Alzheimer's disease.
    Thompson TA; Wilson PH; Snyder PJ; Pietrzak RH; Darby D; Maruff P; Buschke H
    Arch Clin Neuropsychol; 2011 Aug; 26(5):412-24. PubMed ID: 21613302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Spanish Instrument Protocol: design and implementation of a study to evaluate treatment efficacy Instruments for Spanish-speaking patients with Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Sano M; Mackell JA; Ponton M; Ferreira P; Wilson J; Pawluczyk S; Pfeiffer E; Thomas RG; Jin S; Schafer K; Schittini M; Grundman M; Ferris SH; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S57-64. PubMed ID: 9236954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a neuropsychological battery for the Leukoaraiosis and Disability in the Elderly Study (LADIS): experience and baseline data.
    Madureira S; Verdelho A; Ferro J; Basile AM; Chabriat H; Erkinjuntti T; Fazekas F; Hennerici M; O'brien J; Pantoni L; Salvadori E; Scheltens P; Visser MC; Wahlund LO; Waldemar G; Wallin A; Inzitari D;
    Neuroepidemiology; 2006; 27(2):101-16. PubMed ID: 16943684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Category Cued Recall test in very mild Alzheimer's disease: discriminative validity and correlation with semantic memory functions.
    Vogel A; Mortensen EL; Gade A; Waldemar G
    Eur J Neurol; 2007 Jan; 14(1):102-8. PubMed ID: 17222122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the utility of everyday memory test and the Alzheimer's Disease Assessment Scale-Cognitive part for evaluation of mild cognitive impairment and very mild Alzheimer's disease.
    Adachi H; Shinagawa S; Komori K; Toyota Y; Mori T; Matsumoto T; Sonobe N; Kashibayashi T; Ishikawa T; Fukuhara R; Ikeda M
    Psychiatry Clin Neurosci; 2013 Apr; 67(3):148-53. PubMed ID: 23581865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicenter evaluation of new instruments for Alzheimer's disease clinical trials: summary of results. The Alzheimer's Disease Cooperative Study.
    Mackell JA; Ferris SH; Mohs R; Schneider L; Galasko D; Whitehouse P; Schmitt F; Sano M; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S65-9. PubMed ID: 9236955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How well do the ADAS-cog and its subscales measure cognitive dysfunction in Alzheimer's disease?
    Benge JF; Balsis S; Geraci L; Massman PJ; Doody RS
    Dement Geriatr Cogn Disord; 2009; 28(1):63-9. PubMed ID: 19641319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive and functional decline and their relationship in patients with mild Alzheimer's dementia.
    Liu-Seifert H; Siemers E; Sundell K; Price K; Han B; Selzler K; Aisen P; Cummings J; Raskin J; Mohs R
    J Alzheimers Dis; 2015; 43(3):949-55. PubMed ID: 25125457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations.
    Doraiswamy PM; Bieber F; Kaiser L; Connors K; Krishnan KR; Reuning-Scherer J; Gulanski B
    Psychopharmacol Bull; 1997; 33(1):123-8. PubMed ID: 9133763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validity of the Japanese version of Rivermead Behavioural Memory Test for evaluation of everyday memory function in patients with mild Alzheimer's disease].
    Matsuda A; Kazui H; Hirono N; Mori E
    No To Shinkei; 2002 Aug; 54(8):673-8. PubMed ID: 12355878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.